Furthermore, GM-CSF-armed oHSV2 (oHSV2-mGM) directly stimulates M1 polarization of macrophages in vitro and synergizes with αPD-1 therapy in vivo, achieving complete tumor remission by reversing post-ablation immunosuppression [111]. The gene discussed is CSF2; the disease is neoplasm.